Login to Your Account

Cytheris Receives €1.5M Loan for HCV Clinical Development

By James Etheridge

Wednesday, July 23, 2008

No Abstract


BioWorld International Correspondent

PARIS - Cytheris SA has received a €1.5 million (US$2.3 million) interest-free loan from OSEO, France's national industrial innovation agency, to support its continuing clinical development program in hepatitis C (HCV).

The funds will enable Paris-based Cytheris to push ahead with the development of its lead product, recombinant human Interleukin-7 (r-hIL-7), a critical growth factor for immune T-cell recovery and enhancement.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription